1. Germany Stocks

  2. •

    Basic Materials

  3. •

    Chemicals
Evonik Industries AG

Evonik Industries AG

EVK.SW
Evonik Industries AGCH flagSwiss Exchange
14.74
CHF
+0.72
- -
6.87BMarket Cap
Evonik Industries AG
EVK.SW
(Swiss Exchange)

Recent

price

14.74

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
26.18
32.09
39.67
32.76
32.53
30.19
23.13
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1.6
1.16
-1
0.48
0.57
0.49
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1.65
1.99
1.68
1.72
1.87
1.49
1.39
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1.15
1.15
1.17
1.17
1.17
1.17
1.01
Dividend per Share
11.54
11.43
11.48
14.5
13.79
16.08
16.42
15.95
16.59
19.25
17.19
19.93
23.55
19.12
19.36
17.4
16.89
Book Value per Share
4.06
4.41
4.59
7.98
7.14
9.28
9.32
2.85
3.42
6.68
4.58
6.96
11.3
7.26
7.4
6.47
5.92
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
466
466
466
466
466
466
463
Basic Weighted Avg Shares
13,300
14,540
13,365
12,708
12,917
13,507
12,732
14,383
13,267
13,108
12,199
14,955
18,488
15,267
15,157
14,069
10,723
Sales/Revenue/Turnover
10.07
12.95
14.25
9.55
8.95
12.13
10.68
8.84
8.5
8.94
6.89
8.22
6.8
-0.65
4.22
4.56
4.9
Operating Margin (%)
799
785
745
638
656
764
747
923
787
984
1,018
1,073
1,568
1,841
1,117
1,203
890
Depreciation Expense
734
1,011
1,165
2,054
568
991
844
713
932
2,106
465
746
540
-465
222
265
227
Net Income, GAAP
17.95
29.23
29.11
27.69
29.93
29.29
32.21
28.57
20.81
18.87
26.46
29.12
39.98
- -
44.7
34.36
31.78
Effective Tax Rate (%)
5.52
6.95
8.72
16.16
4.4
7.34
6.63
4.96
7.02
16.07
3.81
4.99
2.92
-3.05
1.46
1.88
2.12
Profit Margin (%)
3,357
2,469
1,464
2,457
2,512
3,609
5,607
2,143
2,239
3,054
2,037
2,118
3,017
1,856
1,449
1,639
1,876
Working Capital
2,867
2,745
1,464
625
632
1,359
3,230
3,694
3,684
3,701
3,541
3,478
4,041
3,312
2,944
3,295
- -
LT Debt
5,969
5,421
5,460
6,836
6,522
7,576
7,745
7,519
7,825
9,060
8,099
9,372
11,056
8,986
9,100
8,174
7,933
Total Equity
11.48
14.54
15.37
10.19
10.05
13.74
8.92
7.93
7.66
7.51
4.82
6.85
5.19
- -
2.65
3.31
4.31
Return on Invested Capital (%)
11.27
14.89
16.65
27.36
9.55
13.94
9.67
7.64
9.21
17.97
4.53
6.54
4.23
- -
2.46
3.18
3.99
Return on Capital (%)
14.53
18.89
21.82
33.93
8.62
14.24
11.14
9.45
12.3
25.22
5.48
8.62
5.33
-4.68
2.48
3.09
2.77
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
576
- -
- -
LT Borrowings
2,592
- -
- -
LT Finance Leases
703
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
466
466
466
Market Capitalization
- -
7,565
7,454

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
4,967
5,431
5,658
Cash, Cash Equivalents & STI
623
801
587
Accounts Receivable, Net
1,532
1,728
1,885
Inventories
2,300
2,429
2,682
Total Current Liabilities
3,328
3,599
3,782
Payables & Accruals
- -
- -
- -
ST Debt
576
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1.46%
1.21%
-10.18%
Free Cash Flow
2.37%
-0.87%
-20.39%
Net Income, GAAP
-23.32%
-56.33%
19.37%
Sales/Revenue/Turnover
1.22%
4.18%
-7.18%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3,796
3,930
3,832
3,599
15,157
2025
3,777
3,499
- -
3,403
14,069
2026
3,427
3,893
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.33
-0.01
0.48
- -
0.48
2025
0.5
0.26
- -
- -
0.57
2026
0.27
0.18
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
1.09
- -
- -
1.17
2025
- -
1.18
- -
- -
1.17
2026
- -
1
- -
- -
- -
Similar Companies
Badger State Ethanol, LLC (BADG)
Unipar Carbocloro S.A. (UNIP6.SA)
Artius Acquisition Inc. (AACQU)
Lanxess AG (LXS.DE)
Hindustan Organic Chemicals Limited (HOCL.BO)
PURE Bioscience, Inc. (PURE)
Business
Evonik Industries AG (EVK.SW) operates as a leading global specialty chemicals company headquartered in Essen, Germany, with origins tracing back to the 2007 restructuring of RAG AG. The company produces a broad portfolio of specialty chemicals across segments including Specialty Additives for coatings and inks; Nutrition & Care encompassing animal nutrition, health care lipids for mRNA therapies, drug delivery systems, cell culture ingredients, and care solutions such as cosmetic actives and emulsifiers; Smart Materials covering inorganic materials and performance polymers; Performance Materials; and Technology & Infrastructure; with production plants in 27 countries and operations in over 100 countries serving industries like automotive, personal care, pharmaceuticals, and agriculture. Employing around 32,000 people, Evonik generated €15.2 billion in sales and €2.1 billion in adjusted EBITDA in 2024. Recent developments include pausing mergers and acquisitions until 2027 amid a major restructuring involving 2,000 job cuts by end-2026, a focus on biobased solutions and energy transitions, the 2023 acquisition of Novachem for sustainable cosmetics actives integrated into Care Solutions, a partnership with Schneider Electric to automate thermoplastic processing at its Essen site, and showcasing circular polymer innovations at K 2025.